Lv1
10 积分 2025-11-12 加入
Dual Targeting of EGFR and HER2 by a Bispecific Antibody-Drug Conjugate Demonstrates Broad Antitumor Activity in Multiple Solid Tumors
12天前
已完结
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
12天前
已完结
Atomic Interaction S. aureus/Machined and Additive Manufacturing Ti-6Al-4V and Ti-35Nb-7Zr-5Ta Disks for Dental Implants
1个月前
已完结
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
3个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
3个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
3个月前
已完结
Bioactive wound dressings for diabetic foot ulcers: Mechanisms, materials, and clinical translation
3个月前
已完结
Effectiveness of Stem Cell Therapy for Diabetic Foot Ulcers: Cell Therapy Alone is Not Enough for Effective Management of Chronic Wounds
3个月前
已关闭
Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment
4个月前
已完结
Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells
4个月前
已完结
皖公网安备34019202002308
